GYALA THERAPEUTICS SL

๐Ÿ“‚ Hardware & Deep Tech๐Ÿ“ Madrid๐Ÿ—“๏ธ Founded: 2020

Unified cybersecurity protecting IT, OT, and IoT infrastructure from advanced threats.

Europe's most interesting startup stories. Every week.

No spam. Unsubscribe anytime.

About GYALA THERAPEUTICS SL

Gyala is an Italian cybersecurity company that has developed a unified platform for protecting IT, OT (operational technology), and IoT infrastructure โ€” providing continuous, real-time threat detection and automated response across the converged environments that define modern industrial and critical infrastructure operations. Originally developed for defense applications, the technology has been extended to serve civilian enterprises that operate complex, high-stakes technical environments where security failures carry consequences well beyond financial loss. The convergence of IT and OT networks in industrial settings โ€” manufacturing plants, energy utilities, transportation systems, healthcare infrastructure โ€” has created a new class of security challenge that traditional IT-centric security tools are poorly equipped to handle. OT systems were designed for reliability and longevity, not security, and many are decades old. Connecting them to IP networks and the broader internet dramatically expands the attack surface while introducing adversaries who are increasingly motivated to target operational infrastructure for disruption, espionage, or extortion. Gyala's platform addresses this challenge through behavioral anomaly detection โ€” analyzing the patterns of normal operation across IT, OT, and IoT devices and flagging deviations that may signal an intrusion or malfunction. When a threat is identified, the system activates automated response measures in real time, replicating the actions of an experienced cybersecurity expert without requiring human intervention at every step. The goal is zero-second response: neutralizing threats before they can propagate through interconnected systems. The company's growth strategy centers on partnerships and ecosystem development, targeting critical infrastructure operators and industrial enterprises where the convergence of IT and OT security is both the most urgent need and the most underserved market. In a threat environment that is growing more sophisticated and more targeted by the year, Gyala's ability to provide unified protection across the full technology stack of a modern industrial organization is a capability that will only become more essential.

The Story

Cybersecurity in wartime: when resilience becomes a variable of the environmental condition. Founded by Andrea Historian and Nicola Mugnato in 2015. Gyala Year of Foundation 2016 Stage Series A | Alive Total raised $9.69 million Last $4.61 million raised | 2 months ago Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

How GYALA THERAPEUTICS SL works

Business Model

B2B model based on services and customized solutions for businesses.

Revenue Model

Recurring revenues from subscription fees or software licenses.

Products & Services

Key Products

  • offrendo una risposta concreta alle sfide di sicurezza piรน complesse
  • garantendo continuitร  operativa in contesti critici

Market & Clients

Key Customers

An Italian technology developed for defense and now also serving civil companies, which detects behavioral anomalies, neutralizes threats, and activates automatic responses in zero seconds, replicating the actions of a cybersecurity expert.

Geographic Presence

ITES

How GYALA THERAPEUTICS SL competes

Competitive Advantages

  • Ability to customize the offering based on customer needs.
  • Presence of a network or community that strengthens distribution.
  • Declared technological differentiation on the product.

How GYALA THERAPEUTICS SL grows

Growth Strategy

The growth strategy appears to be linked to partnerships and ecosystem development.

Distribution Model

Direct distribution with a consultative sales approach.

Moat (Defensibility)

The defendable advantage seems to rely on proprietary technology or know-how.

Funding & Investors

Funding Rounds

  • 2026 - Series A: 2026
  • - Other: $182.2K
  • 2016 - Seed: 31
  • 2016 - Series A: 2016
  • 2022 - Seed: 24

Founding Team

Key Executives

  • Nicola Mugnato - CTO
  • Founder Gian Roberto Sfoglietta - CEO
  • Gian Roberto Sfoglietta - CEO
  • Gian Roberto - CEO

Similar Startups

๐Ÿ“ madrid

DevsHealth SL

AI-powered drug discovery identifying promising compounds and therapeutic candidates more efficiently.

Read Analysis
๐Ÿ“ madrid

Singularly, S.L.

Enterprise-grade AI security platform protecting AI agents and applications from attacks, hallucinations, and data leaks with native cybersecurity solutions.

Read Analysis
๐Ÿ“ madrid

ALIAS ROBOTICS S.L.

Alias Robotics develops AI-driven cybersecurity that automates complex security tasks using intelligent agents, providing continuous protection across modern IT, OT, and robotics systems.

Read Analysis

Sources

๐ŸŽ™๏ธ Scalable Podcast โ€” European startup stories ยท ๐Ÿ‡ฎ๐Ÿ‡น in Italian
Spotify ๐ŸŽง Apple